Round 2 'Innovation' Bills Adopted; Funding Fight Ahead

A second set of bills intended to overhaul the US biomedical enterprise, aimed at accelerating the discovery, development and approval processes for medical products, mostly had smooth sailing through the Senate Health, Education, Labor and Pensions (HELP) Committee on March 9, with only a somewhat brief debate over how the measures will be funded holding up the votes for a short time.

More from Anticancer

More from Therapy Areas